Table 4 Number of disease management actions undertaken by the GPs following positive or negative test results.
Problem | Number of actions following positive test | Number of actions following negative test | Product score § | ||||
|---|---|---|---|---|---|---|---|
|  | No | % †| 95% CI | No | % ‡ | 95% CI |  |
Osteoporosis risk (n = 115) | 62 | 76.5 | 57.4 to 88.8 | 21 | 61.7 | 30.8 to 85.4 | 0.51 |
Urinary incontinence (n = 112) | 51 | 67.1 | 52.2 to 79.2 | 3 | 8.3 | 2.6 to 23.3 | 0.33 |
Hearing loss (n = 114) | 38 | 65.5 | 48.7 to 79.2 | 1 | 1.8 | 0.2 to 15.3 | 0.17 |
Pneumococcal vaccination longer than 3 years ago (n = 113) | 19 | 20.4 | 7.2 to 46.2 | 4 | 20.0 | 5.8 to 50.4 | 0.17 |
Fall risk or balance and gait difficulties (n = 115) | 22 | 45.8 | 28.1 to 64.7 | 16 | 23.9 | 7.1 to 56.3 | 0.14 |
Sleep disorder (n = 114) | 31 | 73.8 | 52.0 to 88.0 | 2 | 2.8 | 0.6 to 28.1 | 0.11 |
Influenza vaccination longer than one year ago (n = 114) | 8 | 15.4 | 2.2 to 60.4 | 12 | 19,4 | 7.8 to 40.6 | 0.08 |
Low vision (n = 110) | 21 | 65.6 | 43.2 to 82.8 | 8 | 10.3 | 3.4 to 27.3 | 0.08 |
Cognitive impairment (n = 114) | 12 | 19.1 | 10.3 to 32.5 | 1 | 2.0 | 0.2 to 17.0 | 0.06 |
Depression (n = 114) | 20 | 58.8 | 29.7 to 82.9 | 1 | 1.3 | 0.1 to 12.6 | 0.05 |
Hyperlipidemia at assessment (n = 113) | 9 | 13.6 | 5.5 to 30.0 | 0 | 0 | Â | 0.04 |
Hypertension at assessment (n = 111) | 4 | 7.5 | 3.4 to 16.0 | 0 | 0 | Â | 0.02 |
Psychosocial deprivation (n = 113) | 6 | 75.0 | 37.0 to 93.9 | 7 | 6.6 | 1.9 to 21.3 | 0.01 |
Hyperglycemia at assessment (n = 112) | 2 | 7.1 | 1.4 to 29.4 | 0 | 0 | 0 | 0.01 |